Loading...
Getting personal with myelodysplastic syndromes: is now the right time?
INTRODUCTION: Commonly used scoring systems rely on blood counts, histological and cytological examination of bone marrow and peripheral blood, and cytogenetic assessments to estimate prognosis of patients with myelodysplastic syndromes (MDS) and guide therapy decisions. Next generation sequencing (...
Na minha lista:
| Udgivet i: | Expert Rev Hematol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6540985/ https://ncbi.nlm.nih.gov/pubmed/30977414 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17474086.2019.1592673 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|